These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3479370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT.
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H.
    Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
    [Abstract] [Full Text] [Related]

  • 8. [Comparative activity of norfloxacin and other chemotherapeutic agents on the adhesion of bacteria of the uro-vaginal tract to uroepithelial cells].
    Carlone NA, Borsotto M, Cuffini AM, Savoia D.
    G Batteriol Virol Immunol; 1985; 78(7-12):185-204. PubMed ID: 3879893
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Galante D, Pennucci C, Esposito S, Barba D.
    Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 13. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO, Izard D, Bryskier A, Leclerc H.
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [Abstract] [Full Text] [Related]

  • 14. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P.
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Gyrase inhibitor].
    Forth W.
    Klin Wochenschr; 1985 Oct 01; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract] [Full Text] [Related]

  • 17. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1989 Oct 01; 15(2):53-8. PubMed ID: 2661182
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S, Phiboonbanakit D, Thunyaharn S, Tantisiriwat W, Santiwatanakul S, Susaengrat W, Srisurat N, Malithong A, Srisangchan P, Thamlikitkul V.
    J Med Assoc Thai; 2012 Feb 01; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
    Lesage D, Delisle-Mizon F, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1985 May 01; 33(5):412-5. PubMed ID: 3162141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.